phenylalanine has been researched along with Hematologic Malignancies in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Armstrong, SA; Austin, R; Breyfogle, LJ; Bruedigam, C; Ebert, BL; Heckl, D; Heidel, FH; Hill, GR; Kalaitzidis, D; Kuhn, CP; Lane, SW; Mullally, A; Poveromo, L; Purdon, A; Vu, T; Williams, DA | 1 |
| Bonnevialle, N; Delhommeau, F; Demur, C; Ducommun, B; Gautier, EF; Giraudier, S; Hexner, E; Laurent, C; Laurent, G; Manenti, S; Mansat-De Mas, V; Marty, C; Picard, M; Récher, C; Villeval, JL | 1 |
2 other study(ies) available for phenylalanine and Hematologic Malignancies
| Article | Year |
|---|---|
Depletion of Jak2V617F myeloproliferative neoplasm-propagating stem cells by interferon-α in a murine model of polycythemia vera.
Topics: Amino Acid Substitution; Animals; Apoptosis; Cell Proliferation; Disease Models, Animal; Hematologic Neoplasms; Humans; Interferon-alpha; Janus Kinase 2; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mutant Proteins; Neoplastic Stem Cells; Phenylalanine; Polycythemia Vera; Valine | 2013 |
The cell cycle regulator CDC25A is a target for JAK2V617F oncogene.
Topics: Amino Acid Substitution; Animals; cdc25 Phosphatases; Cell Cycle; Cells, Cultured; Enzyme Activation; Gene Expression Regulation, Leukemic; Hematologic Neoplasms; Hematopoietic Stem Cells; Humans; Janus Kinase 2; Mice; Mutant Proteins; Oncogenes; Phenylalanine; Up-Regulation; Valine | 2012 |